At a press event today, Belgian health product company Omega Pharma unveiled something it’s calling the E-Waves Phone Chip, a product the company claims neutralizes potentially harmful radiation emitted by mobile phones. Using interference technology, the chip aims to block electromagnetic radiation emitted by mobile devices, particularly in the range between 3 MHz and 10 GHz.
According to Omega Pharma CEO Marc Coucke, research is increasingly showing a link between significant mobiel phone use and the growth of tumors, and cites reports from the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO) warning of possible risks from mobile phone’s EM radiation. Radiation from mobile phones has also been lined to headaches, loss of concentration, and producing heat within the body, although the general medical community has yet to embrace a link between radiation from mobile phones and any adverse health conditions—with the notable exception of contact allergies with materials used in some phones’ cases.
Omega Pharma is rolling out the first 30,000 E-Waves chips in Belgian pharmacies December 10 at a price of €38.95, and plans to introduce the product in other countries soon. Omega Pharma mainly sells over-the-counter healthcare products in western Europe, where it competes with the likes of Bayer, Johnson & Johnson, and Procter & amp; Gamble. Omega Pharma is the largest stand-alone OTC healthcare product company in the world, and claims to be the 11th largest in the world.
